Indoline compounds

US7465811B2 · kind B2 · utility

Assignee

• Laboratoires Fournier SA · FR

Inventors

• Luc Lebreton · Dijon, FR
• Christine Dumas · Talant, FR
• Christine Massardier · Dijon, FR
• Michel Bondoux · Fontaine-lès-Dijon, FR

Key dates

• Filing date: Nov 30, 2007
• Grant date: Dec 16, 2008
• Expiry date: Nov 30, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D413/12
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Sulfonylindoline compounds of formula I,wherein R1 through R4, Y and Z have defined meanings, a process for preparation of such compounds, and the use as pharmaceutically active substances, particularly for the treatment or inhibition of neurodegeneration, cardiovascular disease, inflammatory disease, hypercholesterolemia, dyslipidemia, obesity or diabetes.